Clinical Trial Update: Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of once-daily LEO 90100 aerosol foam in adolescents with plaque psoriasis; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 90100 Aerosol Foam

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-01-15